BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Asterand plc (ATD.L) - Board Changes


7/29/2011 10:50:51 AM

July 29, 2011 -- The Company today announces that Martyn Coombs has decided to step down as Chief Executive Officer, with immediate effect.

Martyn has been responsible for guiding the Company though an exciting period in its development, including the acquisition of BioSeek in 2010 which has added significantly to the Company’s growth prospects.

The Company has immediately commissioned a search process for the new CEO. In the meantime Jack Davis, the Company’s Chairman, will take over the role of Interim CEO.

Jack Davis, the Chairman and Interim CEO, said: “Martyn has been a positive influence as CEO over the last four years and we wish him well for the future.”

The Company continues to experience the trading patterns described in the IMS on 17 May 2011 and, not withstanding the historical weighting towards the second half, the Board remains confident in achieving market expectations for the year as a whole.

Contacts:

Asterand plc

Jack Davis, Chairman and Interim Chief Executive Officer

Tel: + 44 (0) 1763 211 600 / + 1 (313) 263-0960

John Stchur, Chief Financial Officer As above

Buchanan Communications

Lisa Baderoon / Mark Court / Isabel Podda

Tel: +44 (0) 20 7466 5000

Daniel Stewart & Company plc

Antony Legge

Tel: +44 (0) 20 7776 6550

Martin Lampshire

About Asterand

Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information about Asterand, go to www.asterand.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES